Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
4,642.00    14.00 (0.30%)
Bid:
4,616.00
Ask:
4,622.00
Spread: 6.00 (0.13%)
Market Cap: £17.53b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Executive Board changes

28 May 2026 07:15

RNS Number : 9526F
Halma PLC
28 May 2026
 

 

HALMA PLC - EXECUTIVE BOARD CHANGES

Appointment of Sector Chief Executives

Halma plc, the global group of life-saving technology companies focused on growing a safer, cleaner, healthier future for everyone, every day, today announces a change in its Sector Chief Executive leadership.

Constance Baroudel, Environmental & Analysis Sector Chief Executive, will leave Halma at the end of August 2026 to become Chief Executive of Spectris Ltd. Ensuring an orderly transition, she will be succeeded by Steve Brown, currently Healthcare Sector Chief Executive, from 1 September 2026.

As part of this succession, Bill Stoval, currently a Healthcare Sector Divisional Chief Executive, will be promoted to Healthcare Sector Chief Executive, and become a member of our Executive Board.

Constance Baroudel, Environmental & Analysis Sector Chief Executive said: "After eight incredibly fulfilling years at Halma, this is the right moment for me to take on a new leadership challenge. Halma has played a defining role in my career development, giving me the opportunity to grow across a range of leadership roles and to work alongside outstanding companies and colleagues, whom I would like to thank for their dedication and companionship. I am immensely proud of what we have achieved together and remain fully committed to ensuring a smooth and effective handover over the coming months."

Marc Ronchetti, Group Chief Executive, said: "Constance has made an exceptional contribution to Halma in her eight years with the Group and we are grateful for her dedication and impact. I would like to thank her for her partnership and support, and wish her all the best in her new role at Spectris.

I am delighted to appoint Steve and Bill as Sector Chief Executives for Environmental & Analysis and Healthcare, respectively. These changes clearly demonstrate the strength of Halma's succession planning and the depth of leadership talent within the Group.

Steve brings a strong leadership track record and deep experience of Halma's Sustainable Growth Model and culture. He has a proven ability to build close partnerships with our companies across all three sectors, including as a Divisional Chief Executive in the Environmental & Analysis Sector.

Bill's promotion reflects his outstanding leadership within our Healthcare Sector over the last seven years. He has delivered sustainable growth through close collaboration with our companies' leadership teams and through value-accretive acquisitions. His understanding of Halma's purpose-led culture and organisational model make him exceptionally well placed to lead the sector through its next phase of growth."

For further information, please contact: 

Halma plc

Marc Ronchetti, Group Chief ExecutiveCarole Cran, Chief Financial Officer

Melanie Horton, Co-Head of Investor RelationsCharles King, Co-Head of Investor Relations

 

+44 (0)1494 721 111+44 (0)1494 721 111+44 (0)7554 013 396

+44 (0)7776 685 948

MHP

Oliver Hughes/Rachel Farrington/Ollie Hoare

 

+44 (0)7817 458 804 / halma@mhpgroup.com

 

A copy of this announcement, together with other information about Halma, may be viewed on our website www.halma.com.

NOTES

BIOGRAPHIES

Steve Brown: Steve was appointed to the Executive Board in November 2021. He is an experienced Halma leader, having driven success in the business for more than ten years across different roles in all three sectors. Steve has a strong track record of building high-performing teams and delivering organic and acquisition growth. Prior to his appointment as Healthcare Sector Chief Executive, Steve was Divisional Chief Executive of Halma's Environmental & Analysis Sector, Divisional Chief Executive for the Safety Sector and Managing Director of Apollo, one of Halma's largest companies. Steve joined Halma in 2015 from US global industrial company ITW. He holds a Masters in Engineering from the University of Cambridge.

Bill Stoval: Bill is a Divisional Chief Executive in Halma's Healthcare Sector. In his role, Bill chairs the boards of several of Halma's healthcare companies and is responsible for delivering both organic growth and acquisitions. He joined Halma in 2019 following a career spanning over twenty years in the healthcare and technology sectors, including senior roles at major global companies including GE Healthcare and IBM Watson Health where he built and led businesses. Bill brings strong leadership, strategic, operational and entrepreneurial skills and has delivered an impressive track record of organic and acquisition growth at Halma. He holds a Computer Engineering degree from the University of Notre Dame and a Masters in Electrical Engineering from Marquette University, as well as an MBA from the Kellogg School of Management at Northwestern University.

About Halma

Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day. Its purpose defines the three broad market areas where it operates:

 

· Safety

Protecting the safety of people and assets as populations grow and the demand on infrastructure increases.

· Environment

Addressing the impacts of climate change, pollution and waste, protecting life-critical resources and supporting scientific research.

· Healthcare

 

Meeting the increasing demand for better healthcare as chronic illness rises, driven by growing and ageing populations and lifestyle changes.

Halma employs over 9,000 people in more than 20 countries, with major operations in the UK, Mainland Europe, the USA and Asia Pacific. Halma is listed on the London Stock Exchange (LON: HLMA) and is a constituent of the FTSE 100 index.

Halma has been named one of Britain's Most Admired Companies for the past seven years.

 

 

-- Ends --

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAAKOBKOBKDBPB
Date   Source Headline
1st Oct 20197:00 amRNSSite Visit
25th Sep 20197:00 amRNSTrading Statement
29th Jul 20199:44 amRNSDirector/PDMR Shareholding
25th Jul 20196:27 pmRNSResult of AGM
25th Jul 20197:00 amRNSNotice of Board Change
15th Jul 201911:01 amRNSHolding(s) in Company
15th Jul 201910:38 amRNSCompletion of Acquisition
4th Jul 20192:09 pmRNSDirector/PDMR Shareholding
2nd Jul 20194:47 pmRNSDirector/PDMR Shareholding
2nd Jul 201910:34 amRNSHolding(s) in Company
21st Jun 201910:52 amRNSAnnual Financial Report
21st Jun 20197:00 amRNSAcquisition
11th Jun 20197:00 amRNSFinal Results
29th May 20194:00 pmRNSHolding(s) in Company
28th May 201912:59 pmRNSHolding(s) in Company
23rd May 201910:46 amRNSHolding(s) in Company
22nd May 20191:49 pmRNSHolding(s) in Company
21st May 20196:28 pmRNSHolding(s) in Company
17th May 20195:08 pmRNSHolding(s) in Company
13th May 201910:37 amRNSHolding(s) in Company
30th Apr 20199:33 amRNSHolding(s) in Company
17th Apr 201910:13 amRNSHolding(s) in Company
22nd Mar 20199:34 amRNSHolding(s) in Company
21st Mar 201912:30 pmRNSHolding(s) in Company
21st Mar 20197:00 amRNSTrading Statement
7th Feb 20192:00 pmRNSInvestor Event
18th Jan 20197:00 amRNSAcquisition
18th Dec 201811:02 amRNSDirector Declaration
20th Nov 20183:21 pmRNSDoc re. Half Year Report
20th Nov 20187:00 amRNSHalf-year Report
16th Nov 20187:00 amRNSAcquisition
19th Oct 20187:00 amRNSAcquisition
2nd Oct 20184:39 pmRNSDirector/PDMR Shareholding
27th Sep 20187:00 amRNSTrading Statement
2nd Aug 20183:29 pmRNSDirector/PDMR Shareholding
1st Aug 20185:23 pmRNSTotal Voting Rights
27th Jul 201810:39 amRNSDirector/PDMR Shareholding
19th Jul 20184:45 pmRNSResult of AGM
4th Jul 201810:25 amRNSDirector/PDMR Shareholding
26th Jun 20186:06 pmRNSDirector Declaration
19th Jun 20185:23 pmRNSAnnual Financial Report
12th Jun 20187:00 amRNSFinal Results
27th Mar 201810:02 amRNSDirector/PDMR Shareholding
22nd Mar 20187:00 amRNSTrading Statement
9th Feb 20183:49 pmRNSDirector/PDMR Shareholding
7th Feb 20182:00 pmRNSInvestor Event
16th Jan 20187:00 amRNSUS Tax Reform Update
21st Dec 20179:00 amRNSAcquisition
5th Dec 201710:10 amRNSDirector/PDMR Shareholding
21st Nov 20173:10 pmRNSDoc re. Half Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.